Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vaccine candidates in STD.

M A Fletcher1

  • 1Medical Affairs Department, Aventis Pasteur, 2 Avenue Pont Pasteur, F-69367 Lyon Cedex 07, France.

International Journal of STD & AIDS
|June 8, 2001
PubMed
Summary
This summary is machine-generated.

Developing vaccines for sexually transmitted diseases (STDs) faces challenges like immune response issues and pathogen variability. Research focuses on protein antigens and novel approaches for effective STD vaccine development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification of Streptococcus pneumoniae in hospital-acquired pneumonia in adults.

The Journal of hospital infection·2020
Same author

Psychosocial and Neurohormonal Predictors of HIV Disease Progression (CD4 Cells and Viral Load): A 4 Year Prospective Study.

AIDS and behavior·2014
Same author

Pneumococcal empyema and complicated pneumonias: global trends in incidence, prevalence, and serotype epidemiology.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2014
Same author

Reduction in pediatric invasive pneumococcal disease in the Basque Country and Navarre, Spain, after introduction of the heptavalent pneumococcal conjugate vaccine.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2007
Same author

Burden of paediatric invasive pneumococcal disease in Europe, 2005.

Epidemiology and infection·2006
Same author

Controlling invasive pneumococcal disease: is vaccination of at-risk groups sufficient?

International journal of clinical practice·2006
Same journal

Switching to long-acting anti-retroviral therapy with no baseline resistance data: is there value in proviral DNA sequencing? A single-centre pilot study.

International journal of STD & AIDS·2026
Same journal

A precautionary tale of lenacapavir drug-drug interactions: A case series of two persons living with HIV receiving long-acting injections.

International journal of STD & AIDS·2026
Same journal

Long-acting injectable cabotegravir/rilpivirine in a pregnant woman living with HIV with hyperemesis gravidarum:a case report and review of literature.

International journal of STD & AIDS·2026
Same journal

BASHH best practice statement on the management of testosterone-associated vulvovaginitis.

International journal of STD & AIDS·2026
Same journal

Diagnostic accuracy of the Xpert HPV assay in women starting antiretroviral treatment in South Africa.

International journal of STD & AIDS·2026
Same journal

Perceptions of acceptability and preferences surrounding a hypothetical syphilis vaccine in Lima, Peru.

International journal of STD & AIDS·2026
See all related articles

Area of Science:

  • Infectious Diseases
  • Vaccinology
  • Immunology

Background:

  • Sexually transmitted diseases (STDs) pose a significant public health challenge due to infections of the genitourinary tract.
  • Development of effective STD vaccines is hindered by specific scientific obstacles, including incomplete attenuation, immunopathology, poor immunogenicity, and antigenic heterogeneity.

Purpose of the Study:

  • To review the scientific challenges in developing vaccines for sexually transmitted diseases.
  • To explore current and potential strategies for creating effective STD vaccines.

Main Methods:

  • Review of scientific literature on STD vaccine development challenges.
  • Analysis of protein antigens and vaccine approaches for various STDs.

Main Results:

Related Experiment Videos

  • Specific pathogens like human herpes simplex virus type 2, Chlamydia trachomatis, Treponema pallidum, and Neisseria gonorrhoeae present unique vaccine development hurdles.
  • Protein antigens such as haemolysin toxoid, major outer membrane proteins, glycoprotein D, and HPV proteins E6/E7 are being investigated.

Conclusions:

  • Future STD vaccines may utilize live-attenuated viruses, subunit proteins or inactivated whole organisms with adjuvants, or DNA plasmids expressing vaccine antigens.
  • Continued research into diverse vaccine strategies is crucial for overcoming STD challenges and developing prophylactic or therapeutic vaccines.